Measles: Why Is It Coming Back?

For a long time, measles became something many student nurses knew from lectures rather than from placement. Making its return feel strange. If vaccination worked, and the UK had eliminated measles, why are we talking about it again?

The answer starts with one important correction: the UK did not eradicate measles. It achieved elimination of endemic transmission. Those two things are not the same.

Eradication means a disease has been removed worldwide. Elimination means sustained transmission has been interrupted in a particular country or region. Measles can therefore be eliminated from the UK and still be brought in by somebody infected elsewhere. If enough people are susceptible, that imported infection can begin another chain of transmission.

Before we get to why that has happened, it helps to understand the virus itself.

What actually happens when somebody catches measles?

Measles is caused by the measles virus and is one of the most infectious human diseases. It spreads mainly through respiratory particles and can remain infectious in the air and environment for a period after an infected person has left an area. That matters clinically because you do not need prolonged, close contact for transmission to be a concern.

After entering through the respiratory tract, the virus infects local cells and spreads through lymphatic tissue. From there it enters the bloodstream and disseminates around the body. By the time the familiar rash appears, this is not simply a local respiratory infection. It is a systemic viral illness.

The early symptoms can be easy to mistake for another viral infection. Fever is usually accompanied by cough, coryza and conjunctivitis. Koplik spots, small white spots inside the mouth, may appear, but they are not always seen. A few days later the characteristic maculopapular rash usually begins on the face or around the hairline and behind the ears before spreading downwards over the body.

Here is the awkward part from an infection-control point of view: the person is infectious before the rash gives the game away. People with measles are generally infectious from around four days before the rash appears until around four days afterwards.

That is one reason measles can move quickly through a susceptible group. Somebody may have already attended school, travelled, sat in a waiting area or mixed with other people before anyone realises that measles is a possibility.

Measles is sometimes remembered as a childhood illness that causes a fever and rash. That seriously understates it. Complications include otitis media, diarrhoea, pneumonia and encephalitis. Babies, pregnant women and people who are immunosuppressed can be particularly vulnerable to serious disease. A very rare late complication, subacute sclerosing panencephalitis (SSPE), can develop years after the original infection and causes progressive neurological deterioration.

There is no routine antiviral treatment that simply clears uncomplicated measles. Care is mainly supportive, while complications are recognised and managed. Prevention therefore does a huge amount of the work.

So how did measles almost disappear from the UK?

Not because the virus became weaker, and not because it vanished.

The UK introduced routine measles vaccination in 1968, followed by the combined measles, mumps and rubella (MMR) vaccine in 1988 and later a two-dose programme. As vaccine uptake increased, far fewer people were available for the virus to infect.

Think about what measles needs in order to keep circulating. One infectious person has to pass the virus to somebody who is susceptible. That newly infected person then has to find another susceptible person. Keep repeating that process and transmission continues.

Vaccination makes that chain much harder to sustain. If most of the people an infectious person encounters are immune, the virus repeatedly reaches dead ends.

That is why measles elimination is a population story as well as an individual one. The World Health Organization (WHO) uses evidence about sustained transmission, surveillance and virus genotyping when assessing whether endemic measles has been interrupted. Very high two-dose vaccine coverage, around 95%, is needed because measles is so infectious.

The UK achieved measles elimination in 2016. It did not mean there would never be another case. Imported cases could still occur, but they did not have to develop into sustained endemic transmission. Transmission was re-established after major outbreaks, and the unusual reduction in measles circulation during the COVID-19 pandemic later allowed the UK to regain elimination status. In January 2026, the WHO assessment based on 2024 surveillance data confirmed that endemic measles transmission had once again been re-established in the UK. Elimination can be achieved, lost and regained.

There is another bit of UK context worth knowing. Elimination status is assessed for the UK as a whole, but measles activity and vaccination coverage are not identical in England, Scotland, Wales and Northern Ireland. A large outbreak in one part of the UK can therefore affect the UK's overall elimination status even when transmission is much lower elsewhere.

That difference is visible in current surveillance. England has carried most of the recent UK burden, with 983 laboratory-confirmed cases reported between 1 January and 31 August 2026. Scotland reported eight laboratory-confirmed cases in the first quarter of 2026, while Northern Ireland reported no confirmed cases from 19 suspected notifications up to the end of July. Public Health Wales has reported that Wales continued to meet the criteria for elimination even though the UK's overall elimination status had been lost. These figures come from different national surveillance systems and reporting periods, so they should not be treated as a league table. They show something more useful: the UK picture is uneven.

Why can measles come back?

Because elimination only holds while the conditions that stopped sustained transmission are maintained.

Vaccination coverage is part of that. The 2025 to 2026 UK childhood vaccination data show that uptake differs between the four nations and, importantly, within them. At five years of age, first-dose MMR coverage was above 95% in Scotland, while second-dose coverage remained below 95% across the UK. Wales also reports strong uptake in older school-age groups, but inequalities remain. Coverage can vary considerably by area, deprivation and population group.

That matters more with measles than it might first appear. A national percentage can look reassuring while hiding a neighbourhood, school or community where many people are susceptible. The virus does not spread according to the national average. It spreads between the people who actually meet each other.

Missed vaccination is not always a simple story of somebody refusing a vaccine either. Access to services, deprivation, moving between healthcare systems, incomplete records, communication barriers and missed opportunities for catch-up can all contribute. Understanding those gaps is much more useful in nursing practice than assuming every person who is not fully vaccinated is 'vaccine hesitant'.

The childhood immunisation programme has also changed. From 2026, measles protection for eligible children is being delivered through the combined measles, mumps, rubella and varicella (MMRV) programme, with transitional arrangements for children born before the new schedule. The exact programme and delivery arrangements can differ between the four UK nations, so students should use the current national immunisation information for the country in which they are practising rather than assuming one schedule applies unchanged everywhere.

Now put this back onto placement.

Imagine a child arrives with a high temperature, cough and red, watery eyes. Their parent says a rash appeared this morning and seems to be spreading down from the face. They are unsure whether the child has received all of their vaccinations.

You are not expected to diagnose measles as a student nurse. You should, however, recognise that this combination of symptoms and vaccination history matters. Because measles can spread before the diagnosis is confirmed, preventing unnecessary exposure is important. Escalate promptly and follow the infection prevention, isolation and public-health procedures used in your placement area.

The legal notification and public-health processes are not identical across all four UK nations, which is another reason not to memorise an England-specific pathway as if it applies everywhere. Your role is to recognise the concern, communicate it clearly and involve the appropriate registered clinician and local infection-prevention or health-protection team.

And this brings us back to the question at the beginning. Measles did not return because vaccination suddenly stopped working. It returned because a disease can only remain eliminated while sustained transmission continues to be interrupted. When immunity is high, an imported case is much more likely to reach a dead end. When susceptible people accumulate, the virus has somewhere to go.

That is the bigger lesson behind measles elimination. Sometimes a disease becoming rare is evidence that prevention is working, not evidence that prevention is no longer needed.

References

UK Health Security Agency (2026). UK measles and rubella elimination indicators and status.

UK Health Security Agency (2026). Measles: the Green Book chapter.

UK Health Security Agency (2026). Measles epidemiology 2023 to 2026. England surveillance data.

Public Health Scotland (2026). Measles surveillance update, January to March 2026.

Public Health Wales (2026). Vaccine uptake in children in Wales: COVER annual report 2025 to 2026.

Public Health Agency Northern Ireland (2026). Measles infection update.

UK Health Security Agency (2026). Measles, mumps, rubella and varicella (MMRV) vaccination programme.

Nursing and Midwifery Council. The Code.